Large-scale testing (Phase 3)Ended earlyNCT03520959
What this trial is testing
A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)
Who this might be right for
Synovial SarcomaCancerSoft Tissue Sarcoma+2 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 1